BMRN

BioMarin Pharmaceutical Inc.

Price

$60.27

return (12m)

2.14%

p/e

42.23

p/bv

1.83

DIVIDEND YIELD

0.00%

BMRN price

BioMarin Pharmaceutical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BMRN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.15%

3 months

13.08%

1 year

2.14%

2 years

-28.75%

5 years

-23.45%

10 years

-39.88%

Fundamentals BMRN

Valuation

P/E

42.23

Sector -4.03

Industry -4.03

P/BV

1.83

Sector 2.05

Industry 2.05

P/Revenue (PSR)

3.50

Sector -4.26

Industry -4.26

EV/EBITDA

61.17

Sector -238.32

Industry -238.32

EV/EBIT

67.60

Sector -670.55

Industry -670.55

P/EBITDA

23.52

Sector -4.23

Industry -4.23

P/EBIT

27.77

Sector -4.29

Industry -4.29

P/Total Assets

1.32

Sector 1.45

Industry 1.45

P/Ativo Circ. Liq.

5.10

Sector -11.51

Industry -11.51

P/Cap.Giro

2.98

Sector -11.45

Industry -11.45

EPS

1.40

Sector -2.20

Industry -2.20

BVPS

32.35

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

76.53%

Sector 36.28%

Industry 36.28%

EBITDA Margin

22.52%

Sector -16,822.56%

Industry -16,822.56%

EBIT Margin

20.38%

Sector -4,238,732.42%

Industry -4,238,732.42%

Operating Margin

9.72%

Sector -38.78%

Industry -38.78%

Net Profit Margins

8.29%

Sector -39.92%

Industry -39.92%

Giro Ativos

0.09

Sector 0.03

Industry 0.03

Profitability

ROE

4.33%

Sector -65.93%

Industry -65.93%

ROA

3.13%

Sector -66.10%

Industry -66.10%

ROIC

6.86%

Sector -2,918.81%

Industry -2,918.81%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

5.81

Sector 2.91

Industry 2.91

Dívida Líquida/EBITDA

-4.59

Sector -13,526,126.12

Industry -13,526,126.12

Dívida Líquida/EBIT

-5.07

Sector -3.66

Industry -3.66

Dívida Líquida/Patrimônio

-0.13

Sector -1.10

Industry -1.10

Dívida Bruta/Patrimônio

0.23

Sector -0.10

Industry -0.10

Equity/Assets

0.72

Sector 0.42

Industry 0.42

Liabilities/Assets

0.28

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

11.92%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF BioMarin Pharmaceutical ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$60.27

Fair Value

$31.92

Upside Return potential.

-47.03%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals BMRN

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
BMRN	42.23	1.83	4.33%	0.00%	$11.35 B	8.29%
JNJ	30.06	7.44	24.76%	1.99%	$632.34 B	21.48%
PFE	18.39	1.52	8.29%	7.11%	$137.74 B	11.83%
ABBV	126.05	-69.30	-54.98%	2.60%	$458.19 B	5.79%
NVO	11.48	6.93	60.40%	3.79%	$217.68 B	37.15%
MRK	36.33	7.07	19.45%	2.56%	$324.61 B	13.59%
AZN	25.14	5.51	21.93%	1.90%	$261.15 B	17.19%
GILD	17.54	6.90	39.33%	2.47%	$161.64 B	30.99%
BMY	17.28	6.25	36.19%	4.05%	$125.69 B	15.01%
ZTS	11.99	9.80	81.75%	2.74%	$31.69 B	27.79%
REGN	15.66	2.20	14.08%	0.55%	$69.27 B	29.65%
HALO	27.62	43.86	158.82%	0.00%	$9.63 B	23.13%
AMGN	26.05	22.11	84.87%	2.60%	$203.18 B	20.96%
MCK	21.59	-123.30	-570.98%	0.39%	$102.83 B	1.18%
VRTX	28.04	6.28	22.41%	0.00%	$121.66 B	35.51%
CAH	34.58	-20.13	-58.20%	0.89%	$53.78 B	0.62%
HRMY	14.10	2.26	16.00%	0.00%	$2.05 B	16.20%
BIIB	21.68	1.59	7.36%	0.00%	$29.75 B	13.81%
MEDP	34.42	38.99	113.29%	0.00%	$16.92 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BMRN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT BioMarin Pharmaceutical

BioMarin Pharmaceutical Inc.

Average Investor10 user rating

4.0 (3 people)

United States

30 years

Founded: 1996

1999

Time since IPO - 27 years

3.059

Employees

BioMarin Pharmaceutical Inc. (United States) is listed on the Nasdaq and has a market capitalization of $11.35 billion, with shareholders equity totaling $6.21 billion.

The company employs approximately 3.059 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, BioMarin Pharmaceutical Inc. reported $3.24 billion in revenue, generating net income of $268.75 million.

Key financial metrics include a P/E ratio of 42.23, a price-to-book (P/B) ratio of 1.83, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BMRN.

Market cap

$11.35 billion

Net worth

$6.21 billion

$6,212,110,000.00

Assets

$8.59 billion

$8,591,020,000.00

Total Shares Outstanding

192.00 million

192,000,000

Average Daily Trading Volume

$2.09 million

$2,085,074.00

Sector

Health Care

Industry

Biotechnology

BMRN

BMRN revenue and profits

Financial Results BMRN

DRAG THE FRAME TO SEE MORE DATA

BMRN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$850.06 20,98% (12M)

P/E

21.59

0.39%

ROE

-570.98%

P/BV

-123.30

CAH - Cardinal Health

$229.35 48,25% (12M)

P/E

34.58

0.89%

ROE

-58.20%

P/BV

-20.13

JNJ - Johnson & Johnson

$265.95 64,85% (12M)

P/E

30.06

1.99%

ROE

24.76%

P/BV

7.44

MRK - Merck & Co.

$130.76 60,71% (12M)

P/E

36.33

2.56%

ROE

19.45%

P/BV

7.07

AZN - AstraZeneca

$169.64 16,66% (12M)

P/E

25.14

1.90%

ROE

21.93%

P/BV

5.51

ABBV - AbbVie

$256.91 41,83% (12M)

P/E

126.05

2.60%

ROE

-54.98%

P/BV

-69.30

NVO - Novo Nordisk

$49.67 --3,46% (12M)

P/E

11.48

3.79%

ROE

60.40%

P/BV

6.93

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$850.06 20,98% (12 M)

P/L

21.59

0.39%

ROE

-570.98%

P/VP

-123.30

CAH - Cardinal Health

$229.35 48,25% (12 M)

P/L

34.58

0.89%

ROE

-58.20%

P/VP

-20.13

JNJ - Johnson & Johnson

$265.95 64,85% (12 M)

P/L

30.06

1.99%

ROE

24.76%

P/VP

7.44

MRK - Merck & Co.

$130.76 60,71% (12 M)

P/L

36.33

2.56%

ROE

19.45%

P/VP

7.07

AZN - AstraZeneca

$169.64 16,66% (12 M)

P/L

25.14

1.90%

ROE

21.93%

P/VP

5.51

ABBV - AbbVie

$256.91 41,83% (12 M)

P/L

126.05

2.60%

ROE

-54.98%

P/VP

-69.30

NVO - Novo Nordisk

$49.67 --3,46% (12 M)

P/L

11.48

3.79%

ROE

60.40%

P/VP

6.93

Frequently Asked Questions

What is the price of BioMarin Pharmaceutical (BMRN) today?

A cotação de BioMarin Pharmaceutical (BMRN) hoje está em US$ 60.27, com uma variação de 2.14% em relação ao último ano. A cotação de BioMarin Pharmaceutical (BMRN) iniciou o ano negociando na casa dos US$ 59.43 e hoje está em US$ 60.27. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de BioMarin Pharmaceutical (BMRN) e dados de ações do Ibovespa e mercados internacionais.

Quando BioMarin Pharmaceutical (BMRN) paga dividendos?

BioMarin Pharmaceutical (BMRN) não distribuiu dividendos no último ano.

Is BioMarin Pharmaceutical (BMRN) a good investment?

Atualmente, BioMarin Pharmaceutical (BMRN) está cotada a US$ 60.27, com um P/L de 42.23, representando um desvio de 6,962% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 2.14 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 2.14%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy BioMarin Pharmaceutical (BMRN) stock?

Investir em ações de BioMarin Pharmaceutical (BMRN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of BioMarin Pharmaceutical (BMRN) yield today?

A rentabilidade de BioMarin Pharmaceutical (BMRN) foi de 2.15% no último mês, 2.14% no último ano e -23.45% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de BioMarin Pharmaceutical (BMRN) hoje, o investimento total seria de US$ 6,027.00, com base na cotação atual de US$ 60.27.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 6,155.98
Em 5 anos: US$ 4,613.67
Em 10 anos: US$ 3,623.43

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BMRN

BioMarin Pharmaceutical Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BMRN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT BioMarin Pharmaceutical

BioMarin Pharmaceutical Inc.

United States

30 years

1999

3.059

PROFIT X PRICE BMRN

Financial Results BMRN

BMRN cash flow

Asset, Revenue and Profit Growth - BMRN

BMRN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions